ESCITALOPRAM OXALATE

ESCITALOPRAM OXALATE was reported 74217 times

These side effects are most commonly reported by patients taking ESCITALOPRAM OXALATE:

# Side effect Count
0 DRUG INEFFECTIVE 4979
1 FATIGUE 4721
2 NAUSEA 4462
3 OFF LABEL USE 4018
4 HEADACHE 3852
5 DIARRHOEA 3828
6 DIZZINESS 3179
7 DRUG INTERACTION 3151
8 FALL 3140
9 ANXIETY 3058
10 DYSPNOEA 2988
11 CONDITION AGGRAVATED 2805
12 VOMITING 2801
13 DEPRESSION 2672
14 PAIN 2554
15 SOMNOLENCE 2536
16 ASTHENIA 2350
17 MALAISE 2339
18 INSOMNIA 2135
19 COMPLETED SUICIDE 2086
20 ARTHRALGIA 2025
21 TOXICITY TO VARIOUS AGENTS 1948
22 DEATH 1903
23 SUICIDE ATTEMPT 1857
24 INTENTIONAL OVERDOSE 1781
25 TREMOR 1748
26 CONFUSIONAL STATE 1731
27 PYREXIA 1727
28 WEIGHT DECREASED 1717
29 PRURITUS 1694
30 RASH 1693
31 COUGH 1645
32 SUICIDAL IDEATION 1638
33 PNEUMONIA 1615
34 DECREASED APPETITE 1560
35 HYPOTENSION 1544
36 PRODUCT USE IN UNAPPROVED INDICATION 1537
37 PAIN IN EXTREMITY 1533
38 ACUTE KIDNEY INJURY 1522
39 ABDOMINAL PAIN 1492
40 SEROTONIN SYNDROME 1476
41 WEIGHT INCREASED 1444
42 OVERDOSE 1342
43 PRODUCT DOSE OMISSION ISSUE 1342
44 FEELING ABNORMAL 1260
45 CONSTIPATION 1230
46 COVID-19 1205
47 TACHYCARDIA 1170
48 ABDOMINAL PAIN UPPER 1123
49 GAIT DISTURBANCE 1118
50 URINARY TRACT INFECTION 1105
51 ELECTROCARDIOGRAM QT PROLONGED 1101
52 BLOOD PRESSURE INCREASED 1080
53 HYPERTENSION 1070
54 HYPERHIDROSIS 1062
55 FOETAL EXPOSURE DURING PREGNANCY 1053
56 HYPONATRAEMIA 1038
57 ABDOMINAL DISCOMFORT 1025
58 AGITATION 987
59 MYALGIA 987
60 BACK PAIN 982
61 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 974
62 NASOPHARYNGITIS 943
63 ANAEMIA 912
64 LOSS OF CONSCIOUSNESS 912
65 MEMORY IMPAIRMENT 906
66 SYNCOPE 901
67 COMA 893
68 SEIZURE 879
69 PALPITATIONS 878
70 DEHYDRATION 873
71 PULMONARY EMBOLISM 866
72 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 844
73 HYPERSENSITIVITY 841
74 PARAESTHESIA 840
75 ASTHMA 839
76 HALLUCINATION 820
77 DRUG ABUSE 783
78 MUSCLE SPASMS 779
79 SLEEP DISORDER 778
80 VISION BLURRED 778
81 CHILLS 771
82 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 769
83 CHRONIC KIDNEY DISEASE 762
84 PERIPHERAL SWELLING 760
85 BALANCE DISORDER 757
86 CHEST PAIN 754
87 HYPOAESTHESIA 743
88 GENERAL PHYSICAL HEALTH DETERIORATION 734
89 TINNITUS 704
90 PRODUCT SUBSTITUTION ISSUE 689
91 DRUG INTOLERANCE 686
92 RENAL FAILURE 686
93 STRESS 683
94 MIGRAINE 682
95 CARDIO-RESPIRATORY ARREST 663
96 DEPRESSED MOOD 653
97 INTENTIONAL PRODUCT USE ISSUE 650
98 CARDIAC ARREST 649
99 ALOPECIA 647
100 CEREBROVASCULAR ACCIDENT 647
101 SEPSIS 638
102 MUSCULAR WEAKNESS 633
103 WHEEZING 624
104 PRODUCT USE ISSUE 623
105 DISTURBANCE IN ATTENTION 611
106 INFLUENZA 595
107 VERTIGO 591
108 MUSCULOSKELETAL STIFFNESS 580
109 PRODUCTIVE COUGH 579
110 SWOLLEN TONGUE 578
111 DRUG HYPERSENSITIVITY 577
112 ERYTHEMA 573
113 HEART RATE INCREASED 570
114 EYE PAIN 568
115 THROMBOSIS 568
116 OEDEMA PERIPHERAL 562
117 INJECTION SITE PAIN 557
118 COGNITIVE DISORDER 555
119 INFECTION 555
120 VISUAL IMPAIRMENT 552
121 WITHDRAWAL SYNDROME 549
122 METABOLIC ACIDOSIS 543
123 ILLNESS 537
124 CONTUSION 528
125 BRADYCARDIA 527
126 PSORIASIS 527
127 ARTHRITIS 508
128 GASTROINTESTINAL DISORDER 508
129 DYSPHONIA 505
130 RESTLESSNESS 504
131 IRRITABILITY 501
132 PANIC ATTACK 501
133 HOSPITALISATION 500
134 URTICARIA 500
135 INCORRECT DOSE ADMINISTERED 499
136 DEPRESSED LEVEL OF CONSCIOUSNESS 494
137 HYPOKALAEMIA 494
138 MEDICATION ERROR 493
139 NEUTROPENIA 492
140 DRY MOUTH 489
141 DYSPHAGIA 489
142 SWELLING FACE 489
143 ATRIAL FIBRILLATION 487
144 OXYGEN SATURATION DECREASED 487
145 GASTROOESOPHAGEAL REFLUX DISEASE 486
146 DYSKINESIA 485
147 SINUSITIS 485
148 INTENTIONAL SELF-INJURY 484
149 OROPHARYNGEAL PAIN 484
150 CHEST DISCOMFORT 480
151 HAEMOGLOBIN DECREASED 480
152 DEEP VEIN THROMBOSIS 479
153 NIGHTMARE 478
154 MENTAL DISORDER 477
155 ADVERSE DRUG REACTION 475
156 DYSPEPSIA 473
157 HYPOXIA 468
158 HAEMATOCHEZIA 465
159 ALTERED STATE OF CONSCIOUSNESS 458
160 FLUSHING 446
161 SOPOR 444
162 AGGRESSION 443
163 HOT FLUSH 443
164 BRONCHITIS 441
165 WHITE BLOOD CELL COUNT DECREASED 441
166 MAJOR DEPRESSION 439
167 AMNESIA 434
168 JOINT SWELLING 434
169 FULL BLOOD COUNT ABNORMAL 433
170 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 430
171 ABDOMINAL DISTENSION 428
172 LETHARGY 427
173 DYSGEUSIA 424
174 HAEMATEMESIS 424
175 ANGIOEDEMA 420
176 RHABDOMYOLYSIS 417
177 MATERNAL EXPOSURE DURING PREGNANCY 415
178 RHEUMATOID ARTHRITIS 413
179 DRY SKIN 412
180 THROMBOCYTOPENIA 411
181 EMOTIONAL DISTRESS 407
182 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 404
183 ECZEMA 401
184 PLATELET COUNT DECREASED 394
185 SEXUAL DYSFUNCTION 394
186 MOBILITY DECREASED 393
187 DELIRIUM 389
188 PRESYNCOPE 388
189 BLINDNESS 379
190 TREATMENT FAILURE 378
191 TREATMENT NONCOMPLIANCE 377
192 ALANINE AMINOTRANSFERASE INCREASED 376
193 NECK PAIN 376
194 NEUROPATHY PERIPHERAL 375
195 DISORIENTATION 373
196 RECTAL HAEMORRHAGE 373
197 BLOOD GLUCOSE INCREASED 368
198 SEDATION 368
199 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 365
200 DISCOMFORT 363
201 HEAD DISCOMFORT 362
202 INTENTIONAL PRODUCT MISUSE 362
203 THERAPY INTERRUPTED 361
204 DIPLOPIA 360
205 SWELLING 357
206 LUNG DISORDER 356
207 COLITIS ULCERATIVE 355
208 ACCIDENTAL OVERDOSE 353
209 DRUG WITHDRAWAL SYNDROME 352
210 BLOOD PRESSURE DECREASED 351
211 SPEECH DISORDER 351
212 CRYING 349
213 ASCITES 347
214 HAEMATURIA 347
215 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 337
216 MYOCARDIAL INFARCTION 337
217 SKIN EXFOLIATION 337
218 THERAPY NON-RESPONDER 336
219 MULTIPLE SCLEROSIS RELAPSE 335
220 HAEMORRHAGIC STROKE 334
221 ERECTILE DYSFUNCTION 333
222 NODULE 333
223 FEELING HOT 329
224 HYPOGLYCAEMIA 329
225 OBSTRUCTIVE AIRWAYS DISORDER 329
226 HALLUCINATION, VISUAL 327
227 INFLUENZA LIKE ILLNESS 327
228 RENAL IMPAIRMENT 327
229 MANIA 326
230 PRODUCT DOSE OMISSION 325
231 IMPAIRED QUALITY OF LIFE 324
232 GASTROINTESTINAL HAEMORRHAGE 323
233 ANHEDONIA 321
234 FREQUENT BOWEL MOVEMENTS 321
235 ARRHYTHMIA 320
236 DRUG DEPENDENCE 319
237 RHINORRHOEA 318
238 NERVOUSNESS 316
239 RESPIRATORY FAILURE 316
240 MUSCLE TWITCHING 315
241 IMPAIRED WORK ABILITY 307
242 NASAL CONGESTION 307
243 URINARY RETENTION 307
244 CONJUNCTIVITIS ALLERGIC 304
245 SPIROMETRY ABNORMAL 302
246 DRUG DOSE OMISSION 300
247 NORMOCHROMIC NORMOCYTIC ANAEMIA 300
248 PHYSICAL DECONDITIONING 300
249 HYPOTHYROIDISM 299
250 PHOTOPHOBIA 299
251 PSYCHOTIC DISORDER 299
252 RESPIRATORY TRACT INFECTION 299
253 BURNING SENSATION 298
254 OCULAR DISCOMFORT 298
255 EPISTAXIS 297
256 URINARY INCONTINENCE 297
257 ABNORMAL BEHAVIOUR 296
258 DIABETES MELLITUS 294
259 DISEASE PROGRESSION 293
260 AKATHISIA 291
261 OSTEOARTHRITIS 290
262 MYDRIASIS 289
263 BLOOD CREATININE INCREASED 288
264 GENERALISED OEDEMA 288
265 MITE ALLERGY 288
266 DYSARTHRIA 287
267 UNEVALUABLE EVENT 287
268 DUST ALLERGY 286
269 EXPOSURE DURING PREGNANCY 286
270 CROHN^S DISEASE 285
271 HERPES ZOSTER 285
272 MUSCLE RIGIDITY 285
273 MYCOTIC ALLERGY 285
274 ARTERIOSCLEROSIS 283
275 HAEMORRHAGE 283
276 CARDIAC FAILURE 281
277 ASPARTATE AMINOTRANSFERASE INCREASED 280
278 HAEMOPTYSIS 279
279 ORTHOSTATIC HYPOTENSION 279
280 HEAD INJURY 278
281 TUBULOINTERSTITIAL NEPHRITIS 275
282 DELUSION 274
283 DERMATITIS ATOPIC 274
284 DISEASE RECURRENCE 272
285 THERAPY CESSATION 270
286 INFUSION RELATED REACTION 266
287 POISONING DELIBERATE 266
288 HEART RATE DECREASED 265
289 LOSS OF LIBIDO 265
290 HYPERSOMNIA 263
291 POLLAKIURIA 263
292 CARDIAC DISORDER 258
293 TORSADE DE POINTES 254
294 ANGER 252
295 ARTERIOSCLEROSIS CORONARY ARTERY 252
296 EPILEPSY 252
297 HAEMATOMA 248
298 PLEURAL EFFUSION 248
299 UNDERDOSE 248
300 C-REACTIVE PROTEIN INCREASED 247
301 PANCYTOPENIA 247
302 DYSPNOEA EXERTIONAL 245
303 HALLUCINATION, AUDITORY 245
304 AMAUROSIS FUGAX 244
305 APATHY 243
306 HEPATIC ENZYME INCREASED 243
307 RASH PRURITIC 241
308 FEBRILE NEUTROPENIA 239
309 RESPIRATORY ARREST 238
310 NEUROLEPTIC MALIGNANT SYNDROME 236
311 APHASIA 235
312 MYOCLONUS 234
313 PRODUCT QUALITY ISSUE 233
314 UNRESPONSIVE TO STIMULI 233
315 SINUS TACHYCARDIA 232
316 DEMENTIA 229
317 MULTIPLE SCLEROSIS 229
318 PARANOIA 229
319 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 227
320 SURGERY 226
321 SYSTEMIC LUPUS ERYTHEMATOSUS 226
322 BLOOD PRESSURE SYSTOLIC INCREASED 225
323 CEREBRAL HAEMORRHAGE 225
324 GAIT INABILITY 225
325 PARKINSON^S DISEASE 224
326 POOR QUALITY SLEEP 224
327 UPPER RESPIRATORY TRACT INFECTION 223
328 MENTAL IMPAIRMENT 222
329 NIGHT SWEATS 222
330 INJECTION SITE ERYTHEMA 221
331 CARDIOGENIC SHOCK 220
332 PULMONARY FIBROSIS 220
333 THERAPEUTIC PRODUCT EFFECT DECREASED 220
334 URINARY TRACT DISORDER 220
335 LEUKOPENIA 219
336 SMALL FOR DATES BABY 219
337 BLOOD CREATINE PHOSPHOKINASE INCREASED 218
338 DYSURIA 218
339 DRY EYE 217
340 GAMMA-GLUTAMYLTRANSFERASE INCREASED 217
341 NO ADVERSE EVENT 217
342 OEDEMA 217
343 HYPERKALAEMIA 216
344 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 215
345 PREMATURE BABY 215
346 RASH ERYTHEMATOUS 215
347 NEPHROLITHIASIS 214
348 BLOOD POTASSIUM DECREASED 213
349 MOVEMENT DISORDER 212
350 SUSPECTED SUICIDE 212
351 VASCULITIS 212
352 ABNORMAL DREAMS 211
353 ARTHROPATHY 211
354 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 210
355 FLATULENCE 210
356 RHINITIS 210
357 THERAPEUTIC RESPONSE DECREASED 210
358 BLOOD PRESSURE FLUCTUATION 209
359 CONVULSION 209
360 MALIGNANT NEOPLASM PROGRESSION 209
361 MUSCULOSKELETAL PAIN 209
362 RESTLESS LEGS SYNDROME 209
363 CATARACT 207
364 DEVICE DISLOCATION 207
365 PULMONARY OEDEMA 206
366 CARDIAC FAILURE CONGESTIVE 205
367 GINGIVAL PAIN 205
368 HYPOMAGNESAEMIA 205
369 EMOTIONAL DISORDER 204
370 STOMATITIS 203
371 BRONCHIECTASIS 202
372 CARDIAC MURMUR 202
373 MENTAL STATUS CHANGES 201
374 END STAGE RENAL DISEASE 200
375 RIB FRACTURE 200
376 PAROSMIA 199
377 EXTRAPYRAMIDAL DISORDER 198
378 WHITE BLOOD CELL COUNT INCREASED 198
379 BLOOD CHOLESTEROL INCREASED 196
380 GENERALISED TONIC-CLONIC SEIZURE 196
381 PSYCHOMOTOR HYPERACTIVITY 196
382 CELLULITIS 195
383 ADVERSE EVENT 194
384 BLISTER 194
385 LIBIDO DECREASED 194
386 PANCREATITIS 194
387 ENCEPHALOPATHY 193
388 LOWER RESPIRATORY TRACT INFECTION 193
389 MOOD SWINGS 193
390 PSORIATIC ARTHROPATHY 193
391 BONE PAIN 192
392 CYSTITIS 188
393 INFLAMMATION 188
394 NEUROLOGICAL SYMPTOM 188
395 DEVICE ISSUE 187
396 FLUID RETENTION 186
397 HYPOPNOEA 186
398 MOOD ALTERED 186
399 ILL-DEFINED DISORDER 185
400 SLEEP TERROR 185
401 ANAPHYLACTIC REACTION 183
402 HIP FRACTURE 183
403 INJECTION SITE REACTION 182
404 DRUG LEVEL INCREASED 181
405 STEROID DEPENDENCE 181
406 LACTIC ACIDOSIS 180
407 OSTEOPOROSIS 180
408 PARKINSONISM 180
409 ATRIAL SEPTAL DEFECT 179
410 PRODUCT DOSE OMISSION IN ERROR 178
411 PULMONARY ALVEOLAR HAEMORRHAGE 178
412 BODY TEMPERATURE INCREASED 177
413 RESPIRATORY SYMPTOM 177
414 INJECTION SITE PRURITUS 176
415 LIVER DISORDER 176
416 RED BLOOD CELL COUNT DECREASED 176
417 THINKING ABNORMAL 176
418 EYE IRRITATION 175
419 IMPAIRED GASTRIC EMPTYING 174
420 DYSSTASIA 173
421 FEAR 173
422 BURNS SECOND DEGREE 172
423 HEPATIC STEATOSIS 172
424 INJECTION SITE BRUISING 172
425 INTERNATIONAL NORMALISED RATIO INCREASED 172
426 PRODUCT PRESCRIBING ERROR 172
427 BLOOD ALKALINE PHOSPHATASE INCREASED 171
428 PNEUMONIA ASPIRATION 171
429 PULMONARY VASCULITIS 171
430 RENAL INJURY 170
431 SINUS BRADYCARDIA 170
432 CHOLESTASIS 169
433 DRUG WITHDRAWAL SYNDROME NEONATAL 169
434 INJECTION SITE SWELLING 169
435 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 169
436 THROAT IRRITATION 169
437 DEVICE MALFUNCTION 168
438 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 168
439 INTENTIONAL DOSE OMISSION 168
440 CATARRH 167
441 FEELING COLD 167
442 HYPOKINESIA 166
443 COLITIS 165
444 SHOCK 165
445 THERAPEUTIC RESPONSE UNEXPECTED 164
446 FEELING JITTERY 163
447 HYPOCALCAEMIA 163
448 POISONING 163
449 NEURITIS 161
450 LIMB DISCOMFORT 160
451 LIMB INJURY 159
452 BRAIN FOG 158
453 DIVERTICULITIS 158
454 NERVOUS SYSTEM DISORDER 158
455 THERAPEUTIC RESPONSE SHORTENED 158
456 ROAD TRAFFIC ACCIDENT 157
457 HYPOACUSIS 156
458 INTESTINAL OBSTRUCTION 156
459 MIDDLE INSOMNIA 156
460 MULTIPLE ALLERGIES 156
461 HYPERREFLEXIA 154
462 SEPTIC SHOCK 153
463 SLEEP APNOEA SYNDROME 153
464 VIRAL INFECTION 153
465 DRUG-INDUCED LIVER INJURY 152
466 DYSTONIA 152
467 FORCED EXPIRATORY VOLUME DECREASED 152
468 NEUTROPHIL COUNT DECREASED 152
469 BRADYKINESIA 150
470 SKIN DISORDER 150
471 UPPER-AIRWAY COUGH SYNDROME 149
472 ACCIDENTAL EXPOSURE TO PRODUCT 148
473 INCREASED APPETITE 148
474 HYPERTHERMIA 147
475 PULMONARY MASS 147
476 ALCOHOL POISONING 145
477 BLOOD BILIRUBIN INCREASED 145
478 FUNGAL INFECTION 145
479 RASH MACULAR 145
480 RESPIRATORY DISTRESS 144
481 HYPOPHAGIA 143
482 LYMPHOCYTE COUNT DECREASED 143
483 TOTAL LUNG CAPACITY ABNORMAL 143
484 CHOLELITHIASIS 142
485 INTERVERTEBRAL DISC PROTRUSION 142
486 RENAL DISORDER 141
487 TARDIVE DYSKINESIA 141
488 HYPERTONIA 140
489 HYPOTONIA 140
490 ACUTE RESPIRATORY FAILURE 138
491 PRESCRIBED OVERDOSE 138
492 TRANSIENT ISCHAEMIC ATTACK 138
493 CLONUS 137
494 EYE SWELLING 137
495 LIVER FUNCTION TEST INCREASED 137
496 NEURALGIA 137
497 RENAL FAILURE ACUTE 137
498 TRANSAMINASES INCREASED 137
499 COORDINATION ABNORMAL 136
500 PREGNANCY 136
501 DEPRESSIVE SYMPTOM 135
502 LYMPHADENOPATHY 135
503 SEASONAL ALLERGY 135
504 HAEMATOCRIT DECREASED 134
505 SKIN DISCOLOURATION 134
506 FIBROMYALGIA 133
507 PALLOR 133
508 RETCHING 133
509 BLOOD SODIUM DECREASED 132
510 COLITIS MICROSCOPIC 132
511 INTERSTITIAL LUNG DISEASE 132
512 PAIN IN JAW 132
513 PRODUCT ADMINISTRATION ERROR 132
514 WOUND 132
515 AFFECTIVE DISORDER 131
516 AGRANULOCYTOSIS 131
517 BREAST CANCER 131
518 HYPERGLYCAEMIA 131
519 RESPIRATORY DISORDER 131
520 ACNE 130
521 INJURY 130
522 EOSINOPHIL COUNT INCREASED 128
523 GASTRITIS 128
524 UPPER GASTROINTESTINAL HAEMORRHAGE 128
525 ISCHAEMIC STROKE 127
526 TYPE 2 DIABETES MELLITUS 127
527 GASTRIC DISORDER 126
528 BRADYPHRENIA 125
529 MULTIPLE ORGAN DYSFUNCTION SYNDROME 125
530 PRODUCT AVAILABILITY ISSUE 124
531 SKIN BURNING SENSATION 124
532 PANCREATITIS ACUTE 123
533 ABORTION SPONTANEOUS 122
534 GASTRIC ULCER 122
535 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 122
536 VENTRICULAR TACHYCARDIA 122
537 EYE DISORDER 121
538 OCULAR HYPERAEMIA 121
539 SUBDURAL HAEMATOMA 121
540 VENTRICULAR FIBRILLATION 121
541 ANAL INCONTINENCE 120
542 CLOSTRIDIUM DIFFICILE INFECTION 120
543 EAR INFECTION 120
544 HEPATOCELLULAR INJURY 120
545 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 120
546 NEPHROGENIC ANAEMIA 120
547 SKIN LESION 120
548 BLOOD COUNT ABNORMAL 119
549 JAUNDICE 119
550 MELAENA 119
551 FEEDING DISORDER 118
552 MULTIPLE DRUG OVERDOSE INTENTIONAL 117
553 MOUTH ULCERATION 116
554 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 115
555 CIRCULATORY COLLAPSE 114
556 ELECTRIC SHOCK SENSATION 114
557 THIRST 114
558 INITIAL INSOMNIA 113
559 BRONCHIAL SECRETION RETENTION 112
560 ORAL HERPES 112
561 PRESCRIBED UNDERDOSE 112
562 BRAIN INJURY 111
563 CATATONIA 111
564 ACUTE MYOCARDIAL INFARCTION 110
565 ANORGASMIA 110
566 HAEMODYNAMIC INSTABILITY 110
567 JOINT STIFFNESS 110
568 LIVER INJURY 110
569 HYPOMANIA 109
570 MUSCLE TIGHTNESS 109
571 NEOPLASM MALIGNANT 109
572 PSYCHOMOTOR RETARDATION 109
573 UPPER LIMB FRACTURE 109
574 MUSCLE SPASTICITY 108
575 EATING DISORDER 107
576 MATERNAL DRUGS AFFECTING FOETUS 107
577 PNEUMONITIS 107
578 VAGINAL HAEMORRHAGE 107
579 CONTRAINDICATED PRODUCT ADMINISTERED 106
580 HEPATIC FAILURE 106
581 HEPATITIS 106
582 LEUKOCYTOSIS 106
583 STAPHYLOCOCCAL INFECTION 106
584 BEHAVIOUR DISORDER 105
585 BLOOD GLUCOSE DECREASED 105
586 BRUXISM 105
587 JOINT INJURY 105
588 RESPIRATORY DEPRESSION 105
589 SALIVARY HYPERSECRETION 105
590 ANGINA PECTORIS 104
591 DERMATITIS ALLERGIC 104
592 PLASMA CELL MYELOMA 104
593 BIPOLAR DISORDER 103
594 IRRITABLE BOWEL SYNDROME 103
595 KIDNEY INFECTION 103
596 LACRIMATION INCREASED 103
597 SPUTUM CULTURE POSITIVE 103
598 THROAT TIGHTNESS 103
599 EYE PRURITUS 102
600 HERNIA 102
601 REVERSIBLE AIRWAYS OBSTRUCTION 102
602 ATAXIA 101
603 BLOOD PRESSURE DIASTOLIC ABNORMAL 101
604 ELECTROCARDIOGRAM ABNORMAL 101
605 HEPATIC CYTOLYSIS 101
606 TOOTHACHE 101
607 DECREASED ACTIVITY 100
608 DRUG EFFECT INCOMPLETE 100
609 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 100
610 SINUS DISORDER 100
611 SKIN ULCER 100
612 STATUS EPILEPTICUS 100
613 VITAL CAPACITY DECREASED 100
614 VITAMIN D DEFICIENCY 100
615 BEDRIDDEN 99
616 BLOOD IRON DECREASED 99
617 BLOOD PRESSURE ABNORMAL 99
618 EOSINOPHILIA 99
619 MIOSIS 99
620 CHOKING 98
621 MUCOSAL INFLAMMATION 98
622 BLOOD POTASSIUM INCREASED 97
623 DRUG EFFECT DECREASED 97
624 DRUG EXPOSURE DURING PREGNANCY 97
625 HEART RATE IRREGULAR 97
626 IMPAIRED HEALING 97
627 MYOCARDITIS 97
628 PERICARDIAL EFFUSION 97
629 FOOT FRACTURE 96
630 LOCALISED INFECTION 96
631 LONG QT SYNDROME 96
632 OBESITY 96
633 PSYCHIATRIC SYMPTOM 96
634 QUALITY OF LIFE DECREASED 96
635 ABDOMINAL PAIN LOWER 95
636 FEELING OF DESPAIR 95
637 FULL BLOOD COUNT DECREASED 95
638 GOUT 95
639 SKIN HAEMORRHAGE 95
640 THERAPY PARTIAL RESPONDER 95
641 VENTRICULAR SEPTAL DEFECT 95
642 GALACTORRHOEA 94
643 PROCEDURAL PAIN 94
644 ABSCESS 93
645 ECONOMIC PROBLEM 93
646 INJECTION SITE MASS 93
647 MUSCULOSKELETAL CHEST PAIN 93
648 OBSESSIVE-COMPULSIVE DISORDER 93
649 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 93
650 WEIGHT FLUCTUATION 93
651 CAESAREAN SECTION 92
652 CANDIDA INFECTION 92
653 EXTRA DOSE ADMINISTERED 92
654 FAECES DISCOLOURED 92
655 INSURANCE ISSUE 92
656 MUSCULOSKELETAL DISCOMFORT 92
657 PRODUCT ADMINISTRATION INTERRUPTED 92
658 TALIPES 92
659 BODY TEMPERATURE DECREASED 91
660 LIVER FUNCTION TEST ABNORMAL 91
661 TOOTH DISORDER 91
662 TOXIC EPIDERMAL NECROLYSIS 91
663 BLOOD URINE PRESENT 90
664 DRUG TOXICITY 90
665 GLAUCOMA 90
666 HEPATIC FUNCTION ABNORMAL 90
667 INFUSION SITE PAIN 90
668 PANIC REACTION 90
669 PRODUCT DISPENSING ERROR 90
670 RESPIRATORY DISORDER NEONATAL 90
671 CORONARY ARTERY DISEASE 89
672 DEAFNESS 89
673 DIZZINESS POSTURAL 89
674 RASH MACULO-PAPULAR 89
675 SENSORY DISTURBANCE 89
676 WRIST FRACTURE 89
677 ELECTROLYTE IMBALANCE 88
678 HIATUS HERNIA 88
679 LIGAMENT SPRAIN 88
680 SKIN LACERATION 88
681 TASTE DISORDER 88
682 ORAL PAIN 87
683 SCIATICA 87
684 TENSION 87
685 COLD SWEAT 86
686 DRUG ERUPTION 86
687 EAR PAIN 86
688 FACE OEDEMA 86
689 HAEMORRHOIDS 86
690 INCONTINENCE 86
691 OSTEOPENIA 86
692 POST-TRAUMATIC STRESS DISORDER 86
693 EUPHORIC MOOD 85
694 FEMUR FRACTURE 85
695 GESTATIONAL DIABETES 85
696 LIP SWELLING 85
697 MYOPATHY 85
698 SKIN FISSURES 85
699 SPINAL FRACTURE 85
700 BUNDLE BRANCH BLOCK LEFT 84
701 HEPATIC CIRRHOSIS 84
702 INJECTION SITE HAEMORRHAGE 84
703 AGEUSIA 83
704 GASTROENTERITIS VIRAL 83
705 PROTEINURIA 83
706 CARDIOVASCULAR DISORDER 82
707 POOR VENOUS ACCESS 82
708 CEREBRAL HAEMATOMA 81
709 DEVICE BREAKAGE 81
710 HUNGER 81
711 MUSCULOSKELETAL DISORDER 81
712 NEOPLASM PROGRESSION 81
713 TROPONIN INCREASED 81
714 ANKYLOSING SPONDYLITIS 80
715 BLOOD PRESSURE SYSTOLIC ABNORMAL 80
716 CLOSTRIDIUM DIFFICILE COLITIS 80
717 COELIAC DISEASE 80
718 PHOTOSENSITIVITY REACTION 80
719 PREMATURE DELIVERY 80
720 SOMNAMBULISM 80
721 BLOOD UREA INCREASED 79
722 EMOTIONAL POVERTY 79
723 GRAND MAL CONVULSION 79
724 MICTURITION URGENCY 79
725 MULTIPLE DRUG OVERDOSE 79
726 POLYURIA 79
727 SNEEZING 79
728 VENTRICULAR EXTRASYSTOLES 79
729 BLOOD CALCIUM DECREASED 78
730 CARPAL TUNNEL SYNDROME 78
731 MITRAL VALVE INCOMPETENCE 78
732 TACHYPNOEA 78
733 TOOTH FRACTURE 78
734 ANXIETY DISORDER 77
735 MOTOR DYSFUNCTION 77
736 NEUTROPHIL COUNT INCREASED 77
737 ON AND OFF PHENOMENON 77
738 POST PROCEDURAL COMPLICATION 77
739 ACUTE RESPIRATORY DISTRESS SYNDROME 76
740 CONCUSSION 76
741 HEMIPARESIS 76
742 LYMPHOPENIA 76
743 SLEEP TALKING 76
744 THERAPY CHANGE 76
745 CAPILLARITIS 75
746 CEREBRAL INFARCTION 75
747 DECREASED INTEREST 75
748 FOETAL GROWTH RESTRICTION 75
749 POLYDIPSIA 75
750 PULMONARY HYPERTENSION 75
751 REBOUND ACID HYPERSECRETION 75
752 RED BLOOD CELL SEDIMENTATION RATE INCREASED 75
753 TONSILLITIS 75
754 BACTERIAL INFECTION 74
755 DISABILITY 74
756 HEPATOTOXICITY 74
757 PLATELET COUNT INCREASED 74
758 PRODUCT PRESCRIBING ISSUE 74
759 SPUTUM DISCOLOURED 74
760 AMENORRHOEA 73
761 ANKLE FRACTURE 73
762 CONJUNCTIVITIS 73
763 DRUG RESISTANCE 73
764 HALLUCINATIONS, MIXED 73
765 INTERVERTEBRAL DISC DEGENERATION 73
766 TRISMUS 73
767 EAR DISCOMFORT 72
768 INTRUSIVE THOUGHTS 72
769 LABORATORY TEST ABNORMAL 72
770 PERITONITIS 72
771 RED CELL DISTRIBUTION WIDTH INCREASED 72
772 VISUAL ACUITY REDUCED 72
773 ADRENAL INSUFFICIENCY 71
774 BLOOD TRIGLYCERIDES INCREASED 71
775 COAGULOPATHY 71
776 DERMATITIS 71
777 SECRETION DISCHARGE 71
778 ATRIOVENTRICULAR BLOCK 70
779 BUNDLE BRANCH BLOCK RIGHT 70
780 DEREALISATION 70
781 EXPOSURE VIA BREAST MILK 70
782 FAECALOMA 70
783 HAEMORRHAGE INTRACRANIAL 70
784 HOSPICE CARE 70
785 HYPERPARATHYROIDISM SECONDARY 70
786 NERVE COMPRESSION 70
787 PERSECUTORY DELUSION 70
788 PROSTATE CANCER 70
789 RESPIRATORY TRACT CONGESTION 70
790 SKIN IRRITATION 70
791 SMALL INTESTINAL OBSTRUCTION 70
792 SUICIDAL BEHAVIOUR 70
793 ASPIRATION 69
794 BLADDER DISORDER 69
795 EXPIRED PRODUCT ADMINISTERED 69
796 GENITAL HYPOAESTHESIA 69
797 HYPERNATRAEMIA 69
798 IMPULSIVE BEHAVIOUR 69
799 NOCTURIA 69
800 PAIN OF SKIN 69
801 POTENTIATING DRUG INTERACTION 69
802 SPINAL PAIN 69
803 CYANOSIS 68
804 DEVICE OCCLUSION 68
805 GASTROINTESTINAL PAIN 68
806 GLOMERULAR FILTRATION RATE DECREASED 68
807 PHARYNGITIS 68
808 SELF-INJURIOUS IDEATION 68
809 SYNOVITIS 68
810 TOOTH INFECTION 68
811 ALCOHOLISM 67
812 APHTHOUS ULCER 67
813 BONE DISORDER 67
814 CENTRAL NERVOUS SYSTEM LESION 67
815 EXPOSURE VIA SKIN CONTACT 67
816 GINGIVAL BLEEDING 67
817 KNEE ARTHROPLASTY 67
818 NASAL POLYPS 67
819 PHARYNGEAL SWELLING 67
820 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 67
821 BRAIN OEDEMA 66
822 DEMENTIA ALZHEIMER^S TYPE 66
823 IRON DEFICIENCY ANAEMIA 66
824 NYSTAGMUS 66
825 RESPIRATORY RATE INCREASED 66
826 SARS-COV-2 TEST POSITIVE 66
827 SCAR 66
828 SEDATION COMPLICATION 66
829 STEVENS-JOHNSON SYNDROME 66
830 SUBARACHNOID HAEMORRHAGE 66
831 TORTICOLLIS 66
832 TOXIC ENCEPHALOPATHY 66
833 YAWNING 66
834 AFFECT LABILITY 65
835 BONE DENSITY DECREASED 65
836 CHROMATURIA 65
837 COMA SCALE ABNORMAL 65
838 DRUG USE DISORDER 65
839 DYSGRAPHIA 65
840 HYPERAESTHESIA 65
841 IRON DEFICIENCY 65
842 LIPASE INCREASED 65
843 LOWER LIMB FRACTURE 65
844 SINUS CONGESTION 65
845 SKIN INFECTION 65
846 SUDDEN DEATH 65
847 ATRIOVENTRICULAR BLOCK COMPLETE 64
848 DEPERSONALISATION/DEREALISATION DISORDER 64
849 DIABETIC KETOACIDOSIS 64
850 FRACTURE 64
851 MALNUTRITION 64
852 SPINAL OSTEOARTHRITIS 64
853 ACTIVITIES OF DAILY LIVING IMPAIRED 63
854 APNOEA 63
855 ASPHYXIA 63
856 ATELECTASIS 63
857 BURSITIS 63
858 CEREBRAL DISORDER 63
859 ECCHYMOSIS 63
860 INFUSION SITE ERYTHEMA 63
861 SENSORY LOSS 63
862 SKIN CANCER 63
863 BLOOD ALBUMIN DECREASED 62
864 BREAST PAIN 62
865 DEVICE LEAKAGE 62
866 FLANK PAIN 62
867 FORMICATION 62
868 HYPERTHYROIDISM 62
869 LIVE BIRTH 62
870 RASH PAPULAR 62
871 SOCIAL AVOIDANT BEHAVIOUR 62
872 TEMPERATURE INTOLERANCE 62
873 ANAPHYLACTIC SHOCK 61
874 DISSOCIATION 61
875 EJECTION FRACTION DECREASED 61
876 NEEDLE ISSUE 61
877 PANIC DISORDER 61
878 PERIPHERAL COLDNESS 61
879 PERSONALITY CHANGE 61
880 SCHIZOPHRENIA 61
881 SPLENOMEGALY 61
882 DRUG EFFECT LESS THAN EXPECTED 60
883 FACIAL PAIN 60
884 GLOSSODYNIA 60
885 HEAVY MENSTRUAL BLEEDING 60
886 HYPERTENSIVE CRISIS 60
887 INJECTION SITE EXTRAVASATION 60
888 INTENTIONAL DRUG MISUSE 60
889 OVERWEIGHT 60
890 STUPOR 60
891 SUBSTANCE ABUSE 60
892 WALKING AID USER 60
893 ANURIA 59
894 DRUG LEVEL DECREASED 59
895 EYE MOVEMENT DISORDER 59
896 GYNAECOMASTIA 59
897 HYPOTHERMIA 59
898 OSTEOMYELITIS 59
899 PARAESTHESIA ORAL 59
900 PSYCHOLOGICAL TRAUMA 59
901 SLUGGISHNESS 59
902 ARTHROPOD BITE 58
903 ORAL CANDIDIASIS 58
904 PRE-EXISTING CONDITION IMPROVED 58
905 SCAB 58
906 TENDERNESS 58
907 UVEITIS 58
908 ACUTE HEPATIC FAILURE 57
909 CYTOLYTIC HEPATITIS 57
910 FRUSTRATION TOLERANCE DECREASED 57
911 HEPATITIS CHOLESTATIC 57
912 HYPERPROLACTINAEMIA 57
913 NORMAL NEWBORN 57
914 PRODUCT DISTRIBUTION ISSUE 57
915 THYROID DISORDER 57
916 TOXIC SKIN ERUPTION 57
917 ACCIDENT 56
918 AUTOIMMUNE DISORDER 56
919 BACK DISORDER 56
920 EXTRASYSTOLES 56
921 GRIP STRENGTH DECREASED 56
922 HOMICIDAL IDEATION 56
923 HYPERACUSIS 56
924 HYPOVOLAEMIA 56
925 IMMUNODEFICIENCY 56
926 MUSCLE ATROPHY 56
927 PULMONARY CONGESTION 56
928 PULSELESS ELECTRICAL ACTIVITY 56
929 RENAL TUBULAR NECROSIS 56
930 SKIN ABRASION 56
931 TACHYPHRENIA 56
932 VITAMIN D DECREASED 56
933 APPETITE DISORDER 55
934 BLOOD PROLACTIN INCREASED 55
935 DECUBITUS ULCER 55
936 DRUG DOSE OMISSION BY DEVICE 55
937 GASTROENTERITIS 55
938 GLYCOSYLATED HAEMOGLOBIN INCREASED 55
939 MYOCARDIAL ISCHAEMIA 55
940 PARALYSIS 55
941 PULMONARY THROMBOSIS 55
942 SCRATCH 55
943 SKIN REACTION 55
944 TOOTH LOSS 55
945 ABNORMAL FAECES 54
946 BASAL CELL CARCINOMA 54
947 CARDIOMYOPATHY 54
948 CYTOKINE RELEASE SYNDROME 54
949 DECREASED IMMUNE RESPONSIVENESS 54
950 DEVICE EXPULSION 54
951 EYE DISCHARGE 54
952 FISTULA 54
953 FOOD ALLERGY 54
954 HAIR TEXTURE ABNORMAL 54
955 HYPERCALCAEMIA 54
956 INCREASED TENDENCY TO BRUISE 54
957 PEMPHIGOID 54
958 PRURITUS GENERALISED 54
959 PYELONEPHRITIS 54
960 SUPRAVENTRICULAR TACHYCARDIA 54
961 BLOOD LACTATE DEHYDROGENASE INCREASED 53
962 COVID-19 PNEUMONIA 53
963 DRUG SCREEN POSITIVE 53
964 FREEZING PHENOMENON 53
965 HAIR COLOUR CHANGES 53
966 HYPERPHAGIA 53
967 JOINT EFFUSION 53
968 LIBIDO INCREASED 53
969 PRODUCT USE COMPLAINT 53
970 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 53
971 SNORING 53
972 BLOOD PRESSURE DIASTOLIC DECREASED 52
973 CORONARY ARTERY OCCLUSION 52
974 HIP ARTHROPLASTY 52
975 HYPERBILIRUBINAEMIA 52
976 INFUSION SITE SWELLING 52
977 NERVE INJURY 52
978 PRODUCT STORAGE ERROR 52
979 PURPURA 52
980 RASH GENERALISED 52
981 ANTICHOLINERGIC SYNDROME 51
982 BLEPHAROSPASM 51
983 CARDIOTOXICITY 51
984 CHOLECYSTITIS 51
985 DERMATITIS CONTACT 51
986 DIABETES MELLITUS INADEQUATE CONTROL 51
987 DRUG ADMINISTRATION ERROR 51
988 ERUCTATION 51
989 GENITAL ANAESTHESIA 51
990 PELVIC PAIN 51
991 POLYP 51
992 PULMONARY ARTERIAL HYPERTENSION 51
993 TEMPERATURE REGULATION DISORDER 51
994 TRICUSPID VALVE INCOMPETENCE 51
995 AUTONOMIC NERVOUS SYSTEM IMBALANCE 50
996 BLOOD THYROID STIMULATING HORMONE INCREASED 50
997 INCOHERENT 50
998 INJECTION SITE RASH 50
999 LOGORRHOEA 50